Bearish
Why Is Humacyte Stock Falling Thursday?
Humacyte's stock fell on Thursday despite reporting positive interim Phase 3 results for its acellular tissue-engineered vessel (ATEV) in dialysis pat...
Bearish
Humacyte's stock fell on Thursday despite reporting positive interim Phase 3 results for its acellular tissue-engineered vessel (ATEV) in dialysis pat...
Neutral
Humacyte, Inc. has filed an 8-K with the SEC regarding a Nasdaq compliance notification. The company's common stock had previously fallen below the mi...